NEOPLASMS, PROSTATE
Clinical trials for NEOPLASMS, PROSTATE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, PROSTATE trials appear
Sign up with your email to follow new studies for NEOPLASMS, PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat prostate cancer: experimental drug enters human trials
Disease control Recruiting nowThis early-stage trial tests a new drug, GSK5458514, designed to help the immune system attack prostate cancer cells. It is for men with metastatic castration-resistant prostate cancer (mCRPC), a type that has spread and stopped responding to hormone therapy. The study will first…
Matched conditions: NEOPLASMS, PROSTATE
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New hope for Hard-to-Treat prostate cancer: experimental drug enters human trials
Disease control Recruiting nowThis study tests an experimental drug called GSK5471713 in about 54 adults with a type of advanced prostate cancer that has spread and stopped responding to standard hormone treatments. The main goals are to check the drug's safety, find the right dose, and see if it can help con…
Matched conditions: NEOPLASMS, PROSTATE
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
AI vs radiologist: who spots prostate cancer better?
Knowledge-focused Recruiting nowThis study looks at whether artificial intelligence (AI) can help radiologists find prostate cancer on MRI scans. About 150 men aged 55-80 who are scheduled for a prostate biopsy will take part. Doctors will compare how well they detect cancer with and without AI assistance. The …
Matched conditions: NEOPLASMS, PROSTATE
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC